The Food And Drug Administration has cleared Novartis' drug Afinitor for a new use in women with advanced breast cancer that has not responded to two other drugs. read more..
FRIDAY, July 20 (Healthday News) -- The U.S. Food and Drug Administration on Friday approved the use of the drug Afinitor (everolimus) for use by women with a particular form of advanced breast cancer. read more..
 |
| This undated photo provided by Genentech Inc. on Jan. 31, 2011 shows a vial of the drug Avastin. Surprising results from two new studies may reopen the debate about the value of Avastin for breast cancer. The drug helped make tumors disappear when given with chemotherapy before surgery to certain women with early-stage disease, doctors found. The FDA recently revoked Avastin's approval for advance |
Surprising results from two new studies may reopen debate about the value of Avastin for breast cancer. The drug helped make tumors disappear in certain women with early-stage disease, researchers found. read more..
